TACI-Fc induces apoptosis of primary myeloma cells
. | Myeloma cell number/culture well . | . | . | . | . | . | . | . | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patient no. . | Control . | TACI-Fc . | DEX . | DEX + TACI-Fc . | Anti-IL-6 MoAb . | Anti-IL-6 MoAb + TACI-Fc . | Anti-IL-6 MoAb + DEX . | Anti-IL-6 MoAb + DEX + TACI-Fc . | |||||||
1 | 113 774 | 97 474 | 81 280 | 56 940 | 120 250 | 98 610 | 37 180 | 23 800 | |||||||
2 | 69 960 | 37 884 | 28 980 | 16 168 | 42 560 | 31 740 | 15 752 | 9 550 | |||||||
3 | 18 864 | 10 494 | 19 800 | 8 400 | 20 692 | 12 096 | 19 008 | 4 344 | |||||||
4 | 34 768 | 30 380 | 30 608 | 14 084 | 16 226 | 16 434 | 7 872 | 5 265 | |||||||
5 | 99 540 | 53 508 | 34 914 | 28 457 | 59 280 | 30 576 | 15 228 | 7 912 | |||||||
6 | 171 000 | 154 400 | 158 420 | 107 100 | 160 056 | 130 764 | 112 624 | 52 920 | |||||||
Median value | 84 750 | 45 696 | 32 761 | 22 312 | 50 920 | 31 158 | 17 380 | 8 731 |
. | Myeloma cell number/culture well . | . | . | . | . | . | . | . | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patient no. . | Control . | TACI-Fc . | DEX . | DEX + TACI-Fc . | Anti-IL-6 MoAb . | Anti-IL-6 MoAb + TACI-Fc . | Anti-IL-6 MoAb + DEX . | Anti-IL-6 MoAb + DEX + TACI-Fc . | |||||||
1 | 113 774 | 97 474 | 81 280 | 56 940 | 120 250 | 98 610 | 37 180 | 23 800 | |||||||
2 | 69 960 | 37 884 | 28 980 | 16 168 | 42 560 | 31 740 | 15 752 | 9 550 | |||||||
3 | 18 864 | 10 494 | 19 800 | 8 400 | 20 692 | 12 096 | 19 008 | 4 344 | |||||||
4 | 34 768 | 30 380 | 30 608 | 14 084 | 16 226 | 16 434 | 7 872 | 5 265 | |||||||
5 | 99 540 | 53 508 | 34 914 | 28 457 | 59 280 | 30 576 | 15 228 | 7 912 | |||||||
6 | 171 000 | 154 400 | 158 420 | 107 100 | 160 056 | 130 764 | 112 624 | 52 920 | |||||||
Median value | 84 750 | 45 696 | 32 761 | 22 312 | 50 920 | 31 158 | 17 380 | 8 731 |
Mononuclear cells from tumor samples of 6 patients with MM were cultured for 4 days in the presence of IL-6 (1 ng/mL) with or without DEX (10−6 M), TACI-Fc (10 μg/mL), or B-E8 anti-IL-6 MoAb (10 μg/mL). At day 4 of culture, the cell count and viability were determined and the percentage of CD 138+ viable plasma cells was determined by flow cytometry.